Peptide detail
HGH Somatropin (Human Growth Hormone Somatropin) is a synthetic peptide hormone identical to the endogenous growth hormone produced by the anterior pituitary gland. Its primary mechanism of action involves binding to growth hormone receptors in target tissues, stimulating the production of insulin-like growth factor 1 (IGF-1) in the liver and other tissues. This promotes cellular growth, proliferation, and regeneration, as well as metabolic processes such as protein synthesis, lipolysis, and carbohydrate metabolism. Primary uses of HGH Somatropin include the treatment of growth hormone deficiency (GHD) in children and adults, Turner syndrome, chronic kidney disease-related growth failure in children, and muscle-wasting conditions associated with HIV/AIDS. It is also used off-label for anti-aging, athletic performance enhancement, and recovery from injuries. Key characteristics of HGH Somatropin include its 191-amino acid sequence, molecular weight of approximately 22 kDa, and its short half-life of about 2–4 hours when administered subcutaneously or intramuscularly. It is typically administered via injection and requires careful dosing to avoid side effects such as joint pain, insulin resistance, and edema. The peptide is highly sensitive to temperature and must be stored refrigerated to maintain stability.